Guidelines for post–myocardial infarction (MI) management emphasize treatment with
statins, β blockers (BBs), and angiotensin-converting enzyme inhibitors (ACEIs) or …

Objectives: We sought to assess the relationship between increasing use of cardiovascular
medications and trends in long-term prognosis after myocardial infarction (MI) in the elderly …

Background: In an accompanying article, we report moderate between-hospital variation in
the postdischarge use of β-blockers, angiotensin-modifying drugs and statins by elderly …

Background—It is unclear whether gender and racial/ethnic gaps in the use of and patient
adherence to β-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor …

Background: Postdischarge use of evidence-based drug therapies has been proposed as a
measure of quality of care for myocardial infarction patients. We examined trends in the use …

Background Publication of population-based analyses of medication use after acute
myocardial infarction (AMI) could encourage the use of effective secondary prevention …

Background There are limited data informing the optimal treatment strategy for acute
myocardial infarction in the oldest old (aged≥ 85 years). The study aim was to examine …

Guidelines recommend long-term use of beta-blockers (BB), statins, and angiotensin-
converting-enzyme-inhibitors or angiotensin-receptor-blockers (ACEI/ARB) after myocardial …

OBJECTIVES: To characterize the relationship between hydroxymethylglutaryl‐CoA
reductase inhibitors (statins) and outcomes in older persons with acute myocardial infarction …

Background There is limited information about the long‐term survival of older patients after
myocardial infarction (MI). Methods and Results CRUSADE (Can rapid risk stratification of …